Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, announced it has received FDA 510(k) clearance to market a newly designed Arrow® VPS® Stylet. The new design allows Teleflex to provide hospitals with a complete offering of single, double and triple lumen pre-loaded, pressure injectable Arrow® PICC with Chlorag+ard® Technology for use with its current Arrow® VPS® Device platform. Together these technologies provide an easy solution for clinicians who are dedicated to reducing central venous catheter malposition while helping prevent microbial colonization and thrombus accumulation on catheter surfaces.
Eliminating chest X-ray, reducing patient exposure to radiation and providing protection against microbial colonization and thrombus accumulation on catheter surfaces is easier than ever now that the single, double and triple lumen Arrow® PICC with Chlorag+ard® Technology is available pre-loaded with the Arrow® VPS® Stylet.
The Arrow® VPS® Device is designed to replace the need for confirmatory chest X-ray in the presence of a steady Blue Bullseye by using state-of-the-art, real-time intravascular Doppler, ECG and advanced algorithmic logic to notify the clinician that the catheter tip has reached the optimal location.
“Vascular access procedures are one of the most commonly performed in the hospital but are inherently high risk. This has a major impact on hospital reimbursement under the Affordable Healthcare Act," said Jay White, President of the Vascular Division of Teleflex. "We are proud to now provide a full offering of pre-loaded Arrow® PICC with Chlorag+ard® Technology for use with our innovative Arrow® VPS® Devices. The combination of these leading technologies allows us to provide cutting-edge tools to help improve patient outcomes and help solve problems faced by the vascular access clinician every day."
Source : finance.yahoo.com